Adverse events of grade 3 or more
| . | Total (N = 78) . |
|---|---|
| Febrile neutropenia | 35 (45%) |
| On days 0-4 after transplantation | 18 (23%) |
| Gastrointestinal | |
| Mucositis | 12 (15%) |
| Nausea | 5 (6%) |
| Diarrhea | 12 (15%) |
| Ileus | 1 (1%) |
| Gastrointestinal bleeding | 1 (1%) |
| Pulmonary | |
| Idiopathic pneumonia syndrome | 15 (19%) |
| Cardiovascular | |
| CHF | 2 (3%) |
| Hypertension | 3 (4%) |
| Thromboembolic event | 1 (1%) |
| Liver | |
| Increased total bilirubin | 9 (12%) |
| Increased ALT | 3 (4%) |
| Renal | 4 (5%) |
| Neurological | |
| Headache | 1 (1%) |
| Confusion | 2 (3%) |
| Hematological | |
| Red cell aplasia because of major ABO incompatibility | 2 (3%) |
| Fluid overload | 5 (6%) |
| Hemorrhagic cystitis | 2 (3%) |
| . | Total (N = 78) . |
|---|---|
| Febrile neutropenia | 35 (45%) |
| On days 0-4 after transplantation | 18 (23%) |
| Gastrointestinal | |
| Mucositis | 12 (15%) |
| Nausea | 5 (6%) |
| Diarrhea | 12 (15%) |
| Ileus | 1 (1%) |
| Gastrointestinal bleeding | 1 (1%) |
| Pulmonary | |
| Idiopathic pneumonia syndrome | 15 (19%) |
| Cardiovascular | |
| CHF | 2 (3%) |
| Hypertension | 3 (4%) |
| Thromboembolic event | 1 (1%) |
| Liver | |
| Increased total bilirubin | 9 (12%) |
| Increased ALT | 3 (4%) |
| Renal | 4 (5%) |
| Neurological | |
| Headache | 1 (1%) |
| Confusion | 2 (3%) |
| Hematological | |
| Red cell aplasia because of major ABO incompatibility | 2 (3%) |
| Fluid overload | 5 (6%) |
| Hemorrhagic cystitis | 2 (3%) |
ABO, A, B, and O blood types; ALT, alanine aminotransferase; CHF, congestive heart failure.